Most people on Ozempic lose between 6% and 7% of their body weight, which works out to roughly 12 to 15 pounds for someone starting at 200 pounds. That’s the average from clinical trials using the 1 mg and 2 mg doses over 40 weeks. But individual results vary enormously: about a third of people lose more than 20% of their body weight, while roughly 10% to 17% lose less than 5%.
What the Clinical Trials Show
The best data comes from the SUSTAIN FORTE trial, which tested both approved Ozempic doses in nearly 1,000 people with type 2 diabetes over 40 weeks. Participants on the 1 mg dose lost an average of 5.6 kg (about 12.3 pounds), while those on the 2 mg dose lost 6.4 kg (about 14.1 pounds). In percentage terms, that’s 6.2% and 7.2% of starting body weight, respectively.
These numbers come from people with type 2 diabetes, which matters because diabetes appears to blunt the weight loss effect. In trials of semaglutide for people without diabetes (using the higher-dose version, Wegovy), average weight loss reached 14.9%, nearly double. So if you’re taking Ozempic primarily for blood sugar control, expect more modest weight loss than the headline numbers you may have seen online, which often come from the non-diabetic weight loss trials.
A Realistic Month-by-Month Timeline
Ozempic is started at a low dose and gradually increased to reduce side effects, so weight loss follows a predictable ramp-up pattern.
In the first month, most people lose 3 to 8 pounds. Some of this is water weight as your body adjusts to smaller portions and fewer carbohydrates. Actual fat loss typically kicks in by the end of week four.
During months one through three, the dose escalation phase, weight loss accelerates. Most people lose 1 to 3 pounds per week during this stretch. By the end of month three, a total loss of 5% to 10% of body weight is common.
Months four through six tend to be the peak effectiveness window. Your body has fully adjusted to the medication, appetite suppression is strongest, and monthly losses of 3 to 5 pounds are typical. After this point, weight loss usually slows and eventually plateaus.
Why Results Vary So Much
Two factors consistently predict lower weight loss with semaglutide: having type 2 diabetes and being male. In clinical trials, women lost 14% to 16.2% of their body weight on average, while men lost 8% to 9.3%. People without diabetes lost about 14.9% compared to 9.6% in those with diabetes.
Across all the major semaglutide trials, 32% to 39.6% of participants were “super responders” who lost more than 20% of their body weight. On the other end, 10.2% to 16.7% were “non-responders” who lost less than 5%. One smaller real-world study found that about 22.5% of patients met the non-responder threshold, defined as losing less than 3% at three months or less than 5% at six months. Researchers are still trying to pin down exactly what separates these groups, but factors like baseline BMI, eating behaviors, insulin resistance, and genetics all likely play a role.
How Ozempic Changes Your Appetite
Ozempic works by mimicking a gut hormone called GLP-1 that your body naturally releases after eating. This hormone does three things simultaneously: it triggers insulin release to manage blood sugar, it activates fullness signals in the brain, and it slows the rate at which food leaves your stomach.
That slower stomach emptying is a big part of why people feel full sooner and stay full longer. You physically can’t eat as much in one sitting. Interestingly, this stomach-slowing effect is strongest after your very first dose and diminishes somewhat over time, which is one reason the medication’s side effects (mostly nausea) tend to fade as your body adjusts.
The brain effects are equally important. Semaglutide dials down the hunger and craving signals that make weight loss so difficult through willpower alone. Many people describe a kind of “food noise” quieting, where they simply stop thinking about food between meals.
Ozempic vs. Wegovy: The Dose Difference
Ozempic and Wegovy contain the exact same drug, semaglutide. The difference is the dose and the approved use. Ozempic maxes out at 2 mg per week and is FDA-approved for type 2 diabetes. Wegovy goes up to 2.4 mg per week and is the only semaglutide injection approved specifically for weight loss.
That higher Wegovy dose translates to more weight loss on average. If your primary goal is losing weight and you don’t have type 2 diabetes, Wegovy at its full dose will generally produce better results than Ozempic. Many of the dramatic weight loss percentages reported in the media come from Wegovy trials, not Ozempic trials, so it’s worth knowing which drug the numbers actually apply to.
What Happens if You Stop
Weight regain after stopping semaglutide is significant and well-documented. A 2025 systematic review in The BMJ found that people regain an average of 0.8 kg (about 1.75 pounds) per month after stopping newer, more effective versions of the drug. Within the first year off the medication, average regain was 9.9 kg (roughly 22 pounds).
To put that in perspective, average weight loss at the time people stopped treatment was 14.7 kg (about 32 pounds) for the more effective medications in this class. The projected timeline to return to baseline weight was about 1.5 years after stopping. In practical terms, most of the weight you lose comes back within a year and a half if you discontinue the medication without making substantial, sustained changes to diet and activity levels. This is why many prescribers frame Ozempic and similar drugs as long-term, potentially lifelong treatments rather than short courses.
Setting Realistic Expectations
If you’re taking Ozempic at the standard diabetes doses (1 mg or 2 mg), a realistic expectation is losing 6% to 7% of your body weight over about 10 months. For a 220-pound person, that’s roughly 13 to 15 pounds. Some people will lose far more, some will lose very little, and the medication works best when combined with changes to eating habits and physical activity.
The people who get the most dramatic results tend to be women, people without type 2 diabetes, and those who make meaningful lifestyle changes alongside the medication. If you’ve been on Ozempic for three months and haven’t lost at least 3% of your starting weight, you may fall into the non-responder category, and it’s worth discussing next steps with whoever prescribed the medication.